Back to Search
Start Over
Synergistic effects of antimicrobial components of the human-derived composite amnion-chorion membrane on bacterial growth.
- Source :
-
Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2024 Oct 07; Vol. 14, pp. 1472737. Date of Electronic Publication: 2024 Oct 07 (Print Publication: 2024). - Publication Year :
- 2024
-
Abstract
- Introduction: The human-derived amnion-chorion membrane (ACM) has endogenous antimicrobial properties, which are important for preventing the colonization and survival of oral bacteria on exposed membranes. This project aimed to decipher the underlying mechanism by identifying the components of ACM that confer antibacterial properties. In addition, the antimicrobial efficacy of these identified components on oral bacteria was assessed.<br />Methods: Four antimicrobial proteins, histone H2A/H2B, cathelicidin LL-37, lactoferrin, and lysozyme, were identified via mass spectrometry in ACM. These proteins were then assessed for their efficacy in killing Streptococcus gordonii Challis. Log-phased bacterial cells were cultured with the commercially available proteins that were identified in ACM, either individually or in combination, at different concentrations. After incubation for 8 or 24 hours, the bacteria were stained with a live/dead viability kit and analyzed via confocal microscopy.<br />Results: The combination of these proteins effectively killed S. gordonii in a dose-dependent fashion after 8 or 24 hours of incubation. When each protein was tested individually, it killed S. gordonii at a much lower efficacy relative to the combinations. The synergistic effects of the antimicrobial protein combinations were also observed in both the viable cell count recovery and minimum inhibitory concentration assays.<br />Discussion: By shedding light on the mechanisms in the ACM's antimicrobial property, this study may raise more awareness of the potential benefit of utilization of a membrane with endogenous antimicrobial properties in regeneration surgeries.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.<br /> (Copyright © 2024 Brummerhop, Lee, Weltman, Tribble, van der Hoeven, Chiu, Hong and Wang.)
- Subjects :
- Humans
Antimicrobial Cationic Peptides pharmacology
Anti-Bacterial Agents pharmacology
Muramidase pharmacology
Muramidase metabolism
Lactoferrin pharmacology
Histones metabolism
Microbial Sensitivity Tests
Antimicrobial Peptides pharmacology
Anti-Infective Agents pharmacology
Amnion metabolism
Streptococcus gordonii drug effects
Streptococcus gordonii growth & development
Streptococcus gordonii physiology
Chorion
Cathelicidins
Drug Synergism
Microbial Viability drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 2235-2988
- Volume :
- 14
- Database :
- MEDLINE
- Journal :
- Frontiers in cellular and infection microbiology
- Publication Type :
- Academic Journal
- Accession number :
- 39435187
- Full Text :
- https://doi.org/10.3389/fcimb.2024.1472737